Search - tctmd.com

Displaying 141 - 160 of 1417

Sort: Relevancy | Date

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

Applying Lessons From the CTSN to Clinical Practice

Presenter: Michael J. Mack, Francesco Maisano

October 30, 2016

Presentation TCT 2016

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials

Presenter: A. Michael Lincoff, Franz-Josef Neumann, John A. Bittl

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Presentation TCT 2016

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Presenter: Felix Mahfoud, Michael A. Weber, Ehtisham Mahmud

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo

October 30, 2016

Presentation TCT 2016

Atrial Fibrillation: Scope of the Problem

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Michael D. Ezekowitz

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann

October 30, 2016

Presentation TCT 2016

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Presenter: Felix Mahfoud, Michael A. Weber

October 30, 2016

Presentation TCT 2016

Recognition and Treatment of Right Ventricular Cardiogenic Shock

Presenter: Stefan K. James, Holger Thiele, Michael J. Lim

October 30, 2016

Advertisement

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

How Good Can Surgical Outcomes Be in Secondary MR?

Applying Lessons From the CTSN to Clinical Practice

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Hypertension Treatment Targets Beyond the Kidneys

Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Is There a Role for PCI of Renal Artery Stenosis in Hypertension Management?

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Atrial Fibrillation: Scope of the Problem

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Implications of Recent Hypertension Studies for Optimal BP Targets and Clinical Practice (SPRINT, PATHWAYS, Others)

Recognition and Treatment of Right Ventricular Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content